- Report
- July 2025
- 136 Pages
Global
From €4193EUR$4,650USD£3,637GBP
- Report
- January 2026
- 180 Pages
Global
From €5365EUR$5,950USD£4,653GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,512GBP
- Report
- June 2026
- 386 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- June 2026
- 372 Pages
Global
From €5275EUR$5,850USD£4,575GBP
- Report
- November 2025
- 140 Pages
Global
From €4373EUR$4,850USD£3,793GBP
- Report
- April 2023
- 113 Pages
Global
From €4283EUR$4,750USD£3,715GBP
- Report
- July 2023
- 164 Pages
Turkey, Middle East, Africa Turkey, Middle East, Africa
From €3111EUR$3,450USD£2,698GBP
- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,158USD£3,142GBP
- Report
- October 2024
- 84 Pages
Global
From €3500EUR$4,158USD£3,142GBP
- Book
- May 2016
North America

The Platelet Transfusion market is a subset of the Blood Banking industry. Platelet transfusions are a medical procedure used to treat patients with low platelet counts, which can lead to excessive bleeding. Platelets are collected from healthy donors and stored in a blood bank before being transfused into a patient. Platelet transfusions are used to treat a variety of conditions, including cancer, thrombocytopenia, and autoimmune disorders.
The Platelet Transfusion market is highly regulated, with strict guidelines for donor selection, storage, and transfusion. Quality assurance is a key component of the market, as platelet transfusions must be safe and effective for the patient. Additionally, the market is highly competitive, with a variety of companies offering platelet transfusions.
Some companies in the Platelet Transfusion market include American Red Cross, Grifols, CSL Behring, and Octapharma. Show Less Read more